Next Article in Journal
Synthesis, Crystal Structure and Cyclic Voltammetric Behavior of N-aroyl-N′-(4′-cyanophenyl)thioureas
Previous Article in Journal
(E)-1-(3-Benzoyl-4-phenyl-1H-pyrrol-1-yl)-3-phenylprop-2-en-1-one
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Short Note

2-(2-(4-Methoxyphenyl)furo[3,2-h]quinolin-3-yl)acetic Acid

by
Boris V. Lichitsky
,
Andrey N. Komogortsev
* and
Valeriya G. Melekhina
N.D. Zelinsky Institute of Organic Chemistry, Russian Academy of Science, Leninsky Pr., 47, 119991 Moscow, Russia
*
Author to whom correspondence should be addressed.
Molbank 2022, 2022(1), M1315; https://doi.org/10.3390/M1315
Submission received: 21 December 2021 / Revised: 7 January 2022 / Accepted: 11 January 2022 / Published: 13 January 2022
(This article belongs to the Section Organic Synthesis)

Abstract

:
A simple and efficient protocol for the synthesis of the previously unknown 2-(2-(4-methoxyphenyl)furo[3,2-h]quinolin-3-yl)acetic acid was elaborated. The suggested method is based on the telescoped multicomponent reaction of 8-hydroxyquinoline, 4-methylglyoxal, and Meldrum’s acid. The studied process includes the initial interaction of the starting compounds in MeCN followed by intramolecular cyclization to the target product in refluxing acetic acid. The advantage of this approach is the application of readily available starting materials, atom economy, and a simple work-up procedure. The structure of the synthesized furylacetic acid derivative was proven by 1H, 13C, 2D-NMR, IR spectroscopy, and high-resolution mass spectrometry.

Graphical Abstract

1. Introduction

8-Hydroxyquinoline (8HQ) and its derivatives have huge and diverse biological activities [1,2,3,4,5,6]. 8HQ is one of the oldest antibacterial agents used by mankind, dating back to before the age of modern antibiotics. The interest in the antibacterial agents of this class has not decreased in the present time [7,8,9,10,11]. Further, the various compounds containing 8HQ moiety possess antiproliferative [12,13,14,15] and antifungal [9,16,17,18] properties, and some derivatives of 8HQ have been tested as neuroprotective agents [19,20,21] and botulinum neurotoxin inhibitors [22]. The structures of some important bioactive derivatives of 8-hydroxyquinoline are shown in Figure 1. Along with pharmacological applications, chelates of 8HQ are used in organic light-emitting diodes (OLEDs) and as fluorescent chemosensors [23,24].
A convenient approach to the synthesis of various derivatives of 8-hydroxyquinoline is the use of the methodology of multicomponent reactions [25,26,27]. The undoubted advantage of these processes is the possibility of one-step synthesis of the target products [28,29,30,31,32]. At the present time, multicomponent reactions employing arylglyoxals as starting compounds have attracted considerable attention [33,34]. The presence of two functional groups in the molecule of these substances allows one to create a wide variety of heterocyclic systems. However, it should be noted that there are no examples in the literature of the joint use of arylglyoxals and 8-hydroxyquinoline in multicomponent reactions. Therefore, the elaboration of novel synthetic methods based on the multicomponent reaction of arylglyoxals and 8HQ is of great interest.

2. Results and Discussion

Herein, we develop a highly efficient approach to synthesize 2-(2-(4-methoxyphenyl)furo [3,2-h]quinolin-3-yl)acetic acid 1 on the basis of the multicomponent reaction (MCR) of 8-hydroxyquinoline 2, 4-methoxyphenylglyoxal 3, and Meldrum’s acid 4 (Scheme 1). Previously, we have demonstrated that similar syntheses of condensed furylacetic acids are achieved through a two-stage telescoped process [35,36,37,38,39]. This approach includes the initial condensation of the starting compounds in acetonitrile (MeCN) and subsequent acid treatment, leading to the target products. It should be noted that the interaction of 8-hydroxyquinoline 2, 4-methoxyphenylglyoxal 3, and Meldrum’s acid 4 in the presence of Et3N in MeCN followed by reflux in acetic acid (AcOH) for 1 h resulted in furylacetic acid 1. As a result of the above-mentioned one-pot telescopic process, the target product was obtained in a 68% yield.
The assumed reaction pathway for the formation of 2-(2-(4-methoxyphenyl)furo[3,2-h]quinolin-3-yl)acetic acid 1 is depicted in Scheme 2. Initially, base-catalyzed condensation of arylglyoxal 2 with Meldrum’s acid 3 leads to unstable aroylmethylene derivative A. Next, the addition of 8-hydroxyquinoline anion B to intermediate A results in the formation of adduct D. Further acid treatment of intermediate D leads to the cleavage of Meldrum’s acid moiety accompanied by the liberation of acetone and CO2 molecules. As a result, unstable γ-ketoacid F was formed. Finally, the cyclization of intermediate F with the elimination of water molecules leads to the target furylacetic acid 1.
For synthesized compound 1, a series of 2D-NMR (HSQC, HMBC, COSY) experiments were carried out (Figures S5–S7). The key HMBC correlations are presented in Figure 2. The methylene group protons have four main correlations: H2-1 to C-2 of the carboxyl group, C-3, C-4, and C-5 of a furan moiety. These correlations indicated the presence of an acetic acid unit attached to a furan fragment.
In summary, a simple and efficient multicomponent protocol for the preparation of novel 2-(2-(4-methoxyphenyl)furo[3,2-h]quinolin-3-yl)acetic acid on the basis of the interaction of 8-hydroxyquinoline, 4-methoxyphenylglyoxal, and Meldrum’s acid was suggested. The use of readily accessible starting materials, along with atom economy and a convenient work-up process, allows one to apply the presented method for the synthesis of a wide range of similar furo[3,2-h]quinolinacetic acids. The structure of the obtained product was established by 1H (Figure S1), 13C (Figure S2), 2D-NMR (Figures S5–S7), IR spectroscopy (Figure S4), and high-resolution mass spectrometry (Figure S3).

3. Materials and Methods

All starting chemicals and solvents were commercially available and were used as received. NMR spectra were recorded with Bruker DRX 300 (300 MHz) and Bruker AV 400 (400 MHz) spectrometers (Billerica, MA, USA) in DMSO-d6. Chemical shifts (ppm) were given relative to solvent signals (DMSO-d6: 2.50 ppm (1H-NMR) and 39.52 ppm (13C-NMR)). High-resolution mass spectra (HRMS) were obtained through a Bruker micrOTOF II instrument (Bruker Daltonik Gmbh, Bremen, Germany) using electrospray ionization (ESI). The melting points were determined using a Kofler hot stage (Dresden, Germany). IR spectra were recorded on a Bruker ALPHA (Santa Barbara, CA 93117, USA) spectrophotometer in a KBr pellet.

Experimental Procedure for the Synthesis of 2-(2-(4-Methoxyphenyl)furo[3,2-h]quinolin-3-yl)Acetic Acid 1

A mixture of 8-hydroxyquinoline 2 (2 mmol, 0.29 g), 4-methoxyphenylglyoxal hydrate 3 (2.4 mmol, 0.44 g), Meldrum’s acid 4 (3 mmol, 0.29 g), and Et3N (2 mmol, 0.28 mL) in 6 mL of MeCN was refluxed for 1 h. Then, the solvent was removed under reduced pressure by a rotary evaporator, AcOH (5 mL) was added to the residue, and the solution was refluxed for 1 h. Finally, the reaction mixture was evaporated in rotary, and the residue was recrystallized from MeCN (4 mL). Pale yellow powder; yield 68% (0.45 g, 1.4 mmol); mp 271–272 °C, Rf = 0.5 (ethyl acetate/methanol = 4:1). 1H-NMR (300 MHz, DMSO-d6) δ 12.72 (br.s, 1H), 8.95 (dd, J = 4.3, 1.7 Hz, 1H), 8.47 (dd, J = 8.3, 1.7 Hz, 1H), 7.90–7.79 (m, 4H), 7.57 (dd, J = 8.3, 4.3 Hz, 1H), 7.17 (d, J = 8.8 Hz, 2H), 3.96 (s, 2H), 3.85 (s, 3H). 13C-NMR (75 MHz, DMSO-d6) δ 171.99, 159.77, 152.71, 150.21, 147.28, 136.59, 135.90, 129.57, 128.26, 125.98, 123.23, 122.36, 120.65, 119.40, 114.63, 109.71, 55.33, 30.10. The key cross peaks (1H-13C) in the 2D-NMR (HMBC) spectrum: H1 – C1 (3.96; 171.99); H1 – C2 (3.96; 109.71); H1 – C3 (3.96; 152.71); H1 – C4 (3.96; 129.57). The IR spectrum (KBr), ν, cm−1: 3047 (O-H), 2834 (C-H), 1715 (C=O), 1611 (C-Caryl), 1572 (C-Caryl), 1179 (C-O). HRMS (ESI-TOF) m/z: [M + H]+ Calcld for C20H15NO4 334.1074; Found 334.1071.

Supplementary Materials

The following are available online: copies of 1H, 13C-NMR, mass, and IR spectra for compound 1. Figure S1: 1H-NMR spectrum (300 MHz) of 1 in DMSO-d6; Figure S2: 13C {1H}-NMR spectrum (75 MHz) of 1 in DMSO-d6; Figure S3: HRMS for compound 1; Figure S4: IR spectrum for compound 1; Figure S5: HSQC-NMR spectrum (400 MHz) for compound 1; Figure S6: HMBC-NMR spectrum (400 MHz) for compound 1; Figure S7: COSY-NMR spectrum (400 MHz) for compound 1.

Author Contributions

A.N.K.—conceptualization, synthesis, spectroscopic analysis, and writing of the manuscript; B.V.L.—conceptualization, synthesis, spectroscopic analysis, and writing of the manuscript. V.G.M.—conceptualization, synthesis, spectroscopic analysis, and writing of the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data for the compounds presented in this study are available in the Supplementary Materials of this article.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Song, Y.; Xu, H.; Chen, W.; Zhan, P.; Liu, X. 8-Hydroxyquinoline: A privileged structure with a broad-ranging pharmacological potential. MedChemComm 2015, 6, 61–74. [Google Scholar] [CrossRef]
  2. Saadeh, H.A.; Sweidan, K.A.; Mubarak, M.S. Recent Advances in the Synthesis and Biological Activity of 8-Hydroxyquinolines. Molecules 2020, 25, 4321. [Google Scholar] [CrossRef] [PubMed]
  3. Gupta, R.; Luxami, V.; Paul, K. Insights of 8-Hydroxyquinolines: A novel target in medicinal chemistry. Bioorg. Chem. 2021, 108, 104633. [Google Scholar] [CrossRef] [PubMed]
  4. Savić-Gajić, I.M.; Savić, I.M. Drug design strategies with metal-hydroxyquinoline complexes. Expert Opin. Drug Discov. 2020, 15, 383–390. [Google Scholar] [CrossRef]
  5. Oliveri, V.; Vecchio, G. 8-Hydroxyquinolines in medicinal chemistry: A structural perspective. Eur. J. Med. Chem. 2016, 120, 252–274. [Google Scholar] [CrossRef] [PubMed]
  6. Prachayasittikul, V.; Prachayasittikul, V.; Prachayasittikul, S.; Ruchirawat, S. 8-Hydroxyquinolines: A review of their metal chelating properties and medicinal applications. Drug Des. Dev. Ther. 2013, 7, 1157–1178. [Google Scholar] [CrossRef] [Green Version]
  7. Patil, S.S.; Thakur, G.A.; Shaikh, M.M. Synthesis, Characterization, and Antibacterial Studies of Mixed Ligand Dioxouranium Complexes with 8-Hydroxyquinoline and Some Amino Acids. ISRN Pharm. 2011, 2011, 1–6. [Google Scholar] [CrossRef] [Green Version]
  8. Cherdtrakulkiat, R.; Boonpangrak, S.; Sinthupoom, N.; Prachayasittikul, S.; Ruchirawat, S.; Prachayasittikul, V. Derivatives (halogen, nitro and amino) of 8-hydroxyquinoline with highly potent antimicrobial and antioxidant activities. Biochem. Biophys. Rep. 2016, 6, 135–141. [Google Scholar] [CrossRef] [Green Version]
  9. Joaquim, A.R.; Reginatto, P.; Lopes, M.S.; Bazana, L.C.G.; Gionbelli, M.P.; Cesare, M.A.D.; Kaminski, T.F.A.; Teixeira, M.L.; Abegg, M.A.; Fuentefria, A.M.; et al. New 8-hydroxyquinoline derivatives highlight the potential of this class for treatment of fungal infections. New J. Chem. 2021, 45, 18158–18170. [Google Scholar] [CrossRef]
  10. Joaquim, A.R.; Gionbelli, M.P.; Gosmann, G.; Fuentefria, A.M.; Lopes, M.S.; Andrade, S.F.D. Novel Antimicrobial 8-Hydroxyquinoline-Based Agents: Current Development, Structure–Activity Relationships, and Perspectives. J. Med. Chem. 2021, 64, 16349–16379. [Google Scholar] [CrossRef]
  11. Wang, X.; Shi, J.; Li, Z.; Li, L.; Zhang, R.; Bai, Y.; Li, J.; Liang, F.; Tang, Y. An 8-Hydroxy-Quinoline Derivative Protects Against Lipopolysaccharide-Induced Lethality in Endotoxemia by Inhibiting HMGB1-Mediated Caspase-11 Signaling. Front. Pharmacol. 2021, 12, 1150. [Google Scholar] [CrossRef] [PubMed]
  12. Zhang, H.-R.; Liu, Y.-C.; Chen, Z.-F.; Meng, T.; Zou, B.-Q.; Liu, Y.-N.; Liang, H. Studies on the structures, cytotoxicity and apoptosis mechanism of 8-hydroxylquinoline rhodium(iii) complexes in T-24 cells. New J. Chem. 2016, 40, 6005–6014. [Google Scholar] [CrossRef]
  13. Krawczyk, M.; Pastuch-Gawolek, G.; Mrozek-Wilczkiewicz, A.; Kuczak, M.; Skonieczna, M.; Musiol, R. Synthesis of 8-hydroxyquinoline glycoconjugates and preliminary assay of their β1,4-GalT inhibitory and anti-cancer properties. Bioorg. Chem. 2019, 84, 326–338. [Google Scholar] [CrossRef]
  14. Choroba, K.; Raposo, L.R.; Palion-Gazda, J.; Malicka, E.; Erfurt, K.; Machura, B.; Fernandes, A.R. In vitro antiproliferative effect of vanadium complexes bearing 8-hydroxyquinoline-based ligands—the substituent effect. Dalton Trans. 2020, 49, 6596–6606. [Google Scholar] [CrossRef]
  15. Chan, S.H.; Chui, C.H.; Chan, S.W.; Kok, S.H.L.; Chan, D.; Tsoi, M.Y.T.; Leung, P.H.M.; Lam, A.K.Y.; Chan, A.S.C.; Lam, K.H.; et al. Synthesis of 8-Hydroxyquinoline Derivatives as Novel Antitumor Agents. ACS Med. Chem. Lett. 2013, 4, 170–174. [Google Scholar] [CrossRef] [Green Version]
  16. Ignatova, M.; Manolova, N.; Rashkov, I.; Markova, N.; Kukeva, R.; Stoyanova, R.; Georgieva, A.; Toshkova, R. 8-Hydroxyquinoline-5-Sulfonic Acid-Containing Poly(Vinyl Alcohol)/Chitosan Electrospun Materials and Their Cu2+ and Fe3+ Complexes: Preparation, Antibacterial, Antifungal and Antitumor Activities. Polymers 2021, 13, 2690. [Google Scholar] [CrossRef]
  17. Yin, X.-D.; Sun, Y.; Lawoe, R.K.; Yang, G.-Z.; Liu, Y.-Q.; Shang, X.-F.; Liu, H.; Yang, Y.-D.; Zhu, J.-K.; Huang, X.-L. Synthesis and anti-phytopathogenic activity of 8-hydroxyquinoline derivatives. RSC Adv. 2019, 9, 30087–30099. [Google Scholar] [CrossRef] [Green Version]
  18. Pippi, B.; Lopes, W.; Reginatto, P.; Silva, F.É.K.; Joaquim, A.R.; Alves, R.J.; Silveira, G.P.; Vainstein, M.H.; Andrade, S.F.; Fuentefria, A.M. New insights into the mechanism of antifungal action of 8-hydroxyquinolines. Saudi Pharm. J. 2019, 27, 41–48. [Google Scholar] [CrossRef] [PubMed]
  19. Di Vaira, M.; Bazzicalupi, C.; Orioli, P.; Messori, L.; Bruni, B.; Zatta, P. Clioquinol, a Drug for Alzheimer’s Disease Specifically Interfering with Brain Metal Metabolism: Structural Characterization of Its Zinc(II) and Copper(II) Complexes. Inorg. Chem. 2004, 43, 3795–3797. [Google Scholar] [CrossRef] [PubMed]
  20. Shachar, D.B.; Kahana, N.; Kampel, V.; Warshawsky, A.; Youdim, M.B.H. Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats. Neuropharmacology 2004, 46, 254–263. [Google Scholar] [CrossRef]
  21. Bareggi, S.R.; Cornelli, U. Clioquinol: Review of Its Mechanisms of Action and Clinical Uses in Neurodegenerative Disorders. CNS Neurosci. Ther. 2012, 18, 41–46. [Google Scholar] [CrossRef] [PubMed]
  22. Caglič, D.; Krutein, M.C.; Bompiani, K.M.; Barlow, D.J.; Benoni, G.; Pelletier, J.C.; Reitz, A.B.; Lairson, L.L.; Houseknecht, K.L.; Smith, G.R.; et al. Identification of Clinically Viable Quinolinol Inhibitors of Botulinum Neurotoxin A Light Chain. J. Med. Chem. 2014, 57, 669–676. [Google Scholar] [CrossRef]
  23. Rohini; Paul, K.; Luxami, V. 8-Hydroxyquinoline Fluorophore for Sensing of Metal Ions and Anions. Chem. Rec. 2020, 20, 1430–1473. [Google Scholar] [CrossRef] [PubMed]
  24. Fazaeli, Y.; Amini, M.M.; Najafi, E.; Mohajerani, E.; Janghouri, M.; Jalilian, A.; Ng, S.W. Synthesis and Characterization of 8-Hydroxyquinoline Complexes of Tin(IV) and Their Application in Organic Light Emitting Diode. J. Fluoresc. 2012, 22, 1263–1270. [Google Scholar] [CrossRef]
  25. Peng, L.; Wu, S.-L.; Xu, J.-X.; Chen, D.-S. An Efficient One-Pot Synthesis of 6,9-Dihydrofuro[3,2-f]Quinoline-8-Carbonitrile Derivatives under Catalyst-Free Conditions. Polycycl. Aromat. Compd. 2021, 1–9. [Google Scholar] [CrossRef]
  26. Li, Z.; Li, X.-J.; Liu, J.-Q.; Wang, X.-S. One-Pot Three-Component Synthesis of 6H-Chromeno[4,3-b] or Cyclopenta[b]Furo[3,2-f]Quinoline Derivatives. J. Heterocycl. Chem. 2017, 54, 2929–2934. [Google Scholar] [CrossRef]
  27. Sun, M.; Yu, Y.-L.; Zhao, L.; Ding, M.-W. One-pot and divergent synthesis of furo[3,2-c]quinolines and quinazolin-4(3H)-ones via sequential isocyanide-based three-component/Staudinger/aza-Wittig reaction. Tetrahedron 2021, 80, 131868. [Google Scholar] [CrossRef]
  28. John, S.E.; Gulati, S.; Shankaraiah, N. Recent advances in multi-component reactions and their mechanistic insights: A triennium review. Org. Chem. Front. 2021, 8, 4237–4287. [Google Scholar] [CrossRef]
  29. Younus, H.A.; Al-Rashida, M.; Hameed, A.; Uroos, M.; Salar, U.; Rana, S.; Khan, K.M. Multicomponent reactions (MCR) in medicinal chemistry: A patent review (2010–2020). Expert Opin. Ther. Pat. 2021, 31, 267–289. [Google Scholar] [CrossRef]
  30. Graebin, C.S.; Ribeiro, F.V.; Rogério, K.R.; Kümmerle, A.E. Multicomponent Reactions for the Synthesis of Bioactive Compounds: A Review. Curr. Org. Synth. 2019, 16, 855–899. [Google Scholar] [CrossRef]
  31. Touré, B.B.; Hall, D.G. Natural Product Synthesis Using Multicomponent Reaction Strategies. Chem. Rev. 2009, 109, 4439–4486. [Google Scholar] [CrossRef]
  32. Ulaczyk-Lesanko, A.; Hall, D.G. Wanted: New multicomponent reactions for generating libraries of polycyclic natural products. Curr. Opin. Chem. Biol. 2005, 9, 266–276. [Google Scholar] [CrossRef] [PubMed]
  33. Mishra, R.; Panday, A.K.; Choudhury, L.H.; Pal, J.; Subramanian, R.; Verma, A. Multicomponent Reactions of Arylglyoxal, 4-Hydroxycoumarin, and Cyclic 1,3-C,N-Binucleophiles: Binucleophile-Directed Synthesis of Fused Five- and Six-Membered N-Heterocycles. Eur. J. Org. Chem. 2017, 2017, 2789–2800. [Google Scholar] [CrossRef]
  34. Chaudhary, A. Arylglyoxals as Versatile Synthons for Heterocycles Through Multi-Component Reactions. Curr. Org. Chem. 2019, 23, 1945–1983. [Google Scholar] [CrossRef]
  35. Komogortsev, A.N.; Lichitsky, B.V.; Melekhina, V.G. Straightforward One-step approach towards novel derivatives of 9-oxo-5,6,7,9-tetrahydrobenzo[9,10]heptaleno[3,2-b]furan-12-yl)acetic acid based on the multicomponent reaction of colchiceine, arylglyoxals and Meldrum’s acid. Tetrahedron Lett. 2021, 78, 153292. [Google Scholar] [CrossRef]
  36. Gorbunov, Y.O.; Lichitsky, B.V.; Komogortsev, A.N.; Mityanov, V.S.; Dudinov, A.A.; Krayushkin, M.M. Synthesis of Condensed Furylacetic Acids Based on Multicomponent Condensation of Heterocyclic Enols with Arylglyoxals and Meldrum’s Acid. Chem. Heterocycl. Compd. 2018, 54, 692–695. [Google Scholar] [CrossRef]
  37. Komogortsev, A.N.; Lichitsky, B.V.; Tretyakov, A.D.; Dudinov, A.A.; Krayushkin, M.M. Investigation of the multicomponent reaction of 5-hydroxy-2-methyl-4H-pyran-4-one with carbonyl compounds and Meldrum’s acid. Chem. Heterocycl. Compd. 2019, 55, 818–822. [Google Scholar] [CrossRef]
  38. Lichitsky, B.V.; Melekhina, V.G.; Komogortsev, A.N.; Minyaev, M.E. A new multicomponent approach to the synthesis of substituted furan-2(5H)-ones containing 4H-chromen-4-one fragment. Tetrahedron Lett. 2020, 61, 152602. [Google Scholar] [CrossRef]
  39. Lichitsky, B.V.; Tretyakov, A.D.; Komogortsev, A.N.; Mityanov, V.S.; Dudinov, A.A.; Gorbunov, Y.O.; Daeva, E.D.; Krayushkin, M.M. Synthesis of substituted benzofuran-3-ylacetic acids based on three-component condensation of polyalkoxyphenols, arylglyoxals and Meldrum’s acid. Mendeleev Commun. 2019, 29, 587–588. [Google Scholar] [CrossRef]
Figure 1. Bioactive 8-hydroxyquinoline derivatives.
Figure 1. Bioactive 8-hydroxyquinoline derivatives.
Molbank 2022 m1315 g001
Scheme 1. Synthesis of 2-(2-(4-methoxyphenyl)furo[3,2-h]quinolin-3-yl)acetic acid 1.
Scheme 1. Synthesis of 2-(2-(4-methoxyphenyl)furo[3,2-h]quinolin-3-yl)acetic acid 1.
Molbank 2022 m1315 sch001
Figure 2. The key HMBC correlations in compound 1.
Figure 2. The key HMBC correlations in compound 1.
Molbank 2022 m1315 g002
Scheme 2. A plausible mechanism for the formation of compound 1.
Scheme 2. A plausible mechanism for the formation of compound 1.
Molbank 2022 m1315 sch002
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Lichitsky, B.V.; Komogortsev, A.N.; Melekhina, V.G. 2-(2-(4-Methoxyphenyl)furo[3,2-h]quinolin-3-yl)acetic Acid. Molbank 2022, 2022, M1315. https://doi.org/10.3390/M1315

AMA Style

Lichitsky BV, Komogortsev AN, Melekhina VG. 2-(2-(4-Methoxyphenyl)furo[3,2-h]quinolin-3-yl)acetic Acid. Molbank. 2022; 2022(1):M1315. https://doi.org/10.3390/M1315

Chicago/Turabian Style

Lichitsky, Boris V., Andrey N. Komogortsev, and Valeriya G. Melekhina. 2022. "2-(2-(4-Methoxyphenyl)furo[3,2-h]quinolin-3-yl)acetic Acid" Molbank 2022, no. 1: M1315. https://doi.org/10.3390/M1315

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop